Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Avid Bioservices, Inc. (NASDAQ: CDMO).

Full DD Report for CDMO

You must become a subscriber to view this report.


Recent News from (NASDAQ: CDMO)

Lucky Seven: Immune Design Takes Off, Institutions Place Bets On Viking Therapeutics
Lucky Seven The Lucky Seven is a swing-trading biotechnology portfolio of seven stocks listed in a way to reflect top picks and risk tolerance. The first three picks are the top picks (in no particular order). Risks are increased the further away a stock sits from #4 (the least risky stoc...
Source: SeekingAlpha
Date: May, 16 2018 03:55
Lucky Seven: Achaogen Likely To Bounce Back
The biotechnology sector ( XBI ) felt good about itself last week. As a result, many of the promising, up-and-coming biotechnology companies saw investors throwing their cash back at them in hopes of profitable returns. We anticipate the trend will continue, at least for a short time: C...
Source: SeekingAlpha
Date: May, 14 2018 08:19
Week 20 Breakout Forecast: Short-Term Picks To Give You An Edge
Breakout Forecast Selections for Week 20: Market conditions continue with high volatility. The positive momentum gauge spent another full week in yellow (medium) moving from a value of 61 last week up to a value of 66 this week. The all time low for the positive momentum selection gauge is 8...
Source: SeekingAlpha
Date: May, 14 2018 07:59
Lucky Seven: Omeros Pops, Exelixis Drops On Phase 3 Flop
Thursday and Friday were eventful days for the Lucky Seven and for biotechnology stocks, in general. It requires portfolio reassessment. First, Some Guidelines Before we begin, I'd like to discuss some additional key points to the purpose of the Lucky Seven portfolio: The goal, for all...
Source: SeekingAlpha
Date: May, 12 2018 00:23
Lucky Seven: Omeros Moves, Array Biopharma May Be Next
iShares Nasdaq Biotechnology ETF ( IBB ) was good for a 0.3% gain within the last three trading days, while the Lucky Seven netted a 2.6% gain. The Lucky Seven portfolio assumes an investor made a $1000 investment, to begin, in each pick. So, the portfolio began with $7,000. Lucky Seven ...
Source: SeekingAlpha
Date: May, 08 2018 15:02
Avid Bioservices Announces Appointment of Magnus Schroeder, Ph.D., as Vice President of Process Sciences
-- Addition of Senior Executive with Significant Process Science Experience Supports Company’s Efforts to Expand and Enhance Process Development Capabilities -- TUSTIN, Calif., May 08, 2018 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicate...
Source: GlobeNewswire
Date: May, 08 2018 08:05
The Best Way To Invest In Pharma And Biotech?
"During the Gold Rush, most would-be miners lost money, but people who sold them picks, shovels, tents and blue-jeans (Levi Strauss) made a nice profit." - Peter Lynch Source Invest in Pharma/Biotech? As a medical student, I tend to dig a little deeper in my company research when I...
Source: SeekingAlpha
Date: April, 30 2018 14:00
Avid Bio expanding capacity, three new customers on board; shares up 10%
Avid Bioservices ( CDMO +10.1% ) is up on average volume on the heels of its update on its buildout of process development capabilities and lab space in Southern California. More news on: Avid Bioservices, Inc., Healthcare stocks news, Stocks on the move, Read more ...
Source: SeekingAlpha
Date: April, 24 2018 10:53
Avid Bioservices Provides Update on Ongoing Expansion of Process Development Capabilities and Laboratory Infrastructure
E nhancements Support New Customer Acquisition Efforts, Highlighted by Recent Signing of Three New Process Development and Manufacturing Agreements TUSTIN, Calif., April 24, 2018 (GLOBE NEWSWIRE) --  Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated contract develo...
Source: GlobeNewswire
Date: April, 24 2018 08:05
Week 16 Breakout Forecast: Short-Term Picks To Give You An Edge
Breakout Forecast Selections for Week 16: Market conditions continue with extreme volatility. The positive momentum gauge has finally moved into the yellow from a value of 14 to a value of 40. Volatility in the market remains at high levels and we have not been above the midpoint value of 60...
Source: SeekingAlpha
Date: April, 15 2018 14:29

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-05-173.523.473.563.44222,558

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-08-1710,03732,04431.3226Cover
2018-08-1612,69461,68620.5784Cover
2018-08-1527,659157,79417.5285Cover
2018-08-1419,60043,81944.7295Short
2018-08-1329,42571,33241.2508Short

* Cover Mode

Short Analysis provided by Squeeze Report. Get a complete short report on CDMO.


About Avid Bioservices, Inc. (NASDAQ: CDMO)

Logo for Avid Bioservices, Inc. (NASDAQ: CDMO)

Not available

 

Contact Information

 

 

Current Management

  • John Bonfiglio / President, CEO
  • Paul Lytle / CFO

Current Share Structure

  • Market Cap: $198,876,994 - 05/15/2018
  • Issue and Outstanding: 55,552,233 - 03/07/2018

 


Recent Filings from (NASDAQ: CDMO)

Amendment to a SC 13D filing
Filing Type: SC 13D/AFiling Source: edgar
Filing Date: April, 17 2018
Amendment to a SC 13D filing
Filing Type: SC 13D/AFiling Source: edgar
Filing Date: April, 17 2018
Amendment to a SC 13D filing
Filing Type: SC 13D/AFiling Source: edgar
Filing Date: April, 09 2018
Amendment to a SC 13D filing
Filing Type: SC 13D/AFiling Source: edgar
Filing Date: April, 06 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 13 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 12 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: March, 12 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 08 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 23 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 20 2018

 

 


Daily Technical Chart for (NASDAQ: CDMO)

Daily Technical Chart for (NASDAQ: CDMO)


Stay tuned for daily updates and more on (NASDAQ: CDMO)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: CDMO)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in CDMO is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. DD Report does not own any shares of CDMO and does not buy, sell, or trade any shares of CDMO. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: http://dd.report/disclaimer/